2022

Katikireddi, S. V. , Kopasker, D. , Pearce, A. , Leyland, A. H. , Rostila, M. and Richiardi, M. (2022) Protocol for a pan-European microsimulation model for health impacts of income and social security policies: health equity and its economic determinants (HEED). BMJ Open, (Accepted for Publication)

Kopasker, D. , Ejebu, O.-Z., Norwood, P. and Ludbrook, A. (2022) Longitudinal study of the effects of price and promotion incentives on purchases of unhealthy foods: evidence for restricting food promotions. BMJ Nutrition, Prevention and Health, (doi: 10.1136/bmjnph-2021-000323) (Early Online Publication)

2021

Elliott, R., Kopasker, D. and Skåtun, D. (2021) Public-sector resource allocation since the financial crisis. International Journal of Manpower, 42(4), pp. 521-536. (doi: 10.1108/IJM-10-2019-0488)

Kopasker, D. (2021) Good work and mental health in the post-Covid era. In: McCann, P. and Vorley, T. (eds.) Productivity and the Pandemic: Challenges and Insights from Covid-19. Edward Elgar Publishing Limited: Cheltenham, UK, pp. 119-131. ISBN 9781800374591 (doi: 10.4337/9781800374607.00015)

Kopasker, D. , Robertson, C., Aucott, L., Vadiveloo, T., Imamura, M., Manson, P., Walker, A., Urquhart, G., Brazelli, M. and Scotland, G. (2021) Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer [ID1605]. Other. Aberdeen HTA Group.

2020

Kopasker, D. , Islam, M. K., Gibson, J., Lau, Y.-S., Sutton, M., Askildsen, J. E., Bond, C. and Elliott, R. (2020) Skill mix and patient outcomes: a multi-country analysis of heart disease and breast cancer patients. Health Policy, 124(10), pp. 1074-1082. (doi: 10.1016/j.healthpol.2020.07.009) (PMID:32792201)

Allanson, P. F., Brown, E. A., Kopasker, D. and Kwiatkowski, A. (2020) An investigation of the stability of patients’ treatment preferences over the course of a clinical trial. Value in Health, 23(6), pp. 775-781. (doi: 10.1016/j.jval.2019.12.011) (PMID:32540236)

Robertson, C., Fielding, S., Walker, A., Kopasker, D. , Vadiveloo, T., Manson, P., Price, G., Brazzelli, M. and Scotland, G. (2020) Lorlatinib for Previously Treated ALK-positive Advanced Non-small-cell Lung Cancer [ID1338]. Other. Aberdeen HTA Group.

2019

Kopasker, D. et al. (2019) Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment. British Journal of Dermatology, 180(4), pp. 902-909. (doi: 10.1111/bjd.16801) (PMID:29782648)

2018

Kopasker, D. , Montagna, C. and Bender, K. A. (2018) Economic insecurity: a socioeconomic determinant of mental health. SSM - Population Health, 6, pp. 184-194. (doi: 10.1016/j.ssmph.2018.09.006) (PMID:30417065) (PMCID:PMC6215053)

2017

Görg, H., Henze, P., Jienwatcharamongkhol, V., Kopasker, D. , Molana, H., Montagna, C. and Sjöholm, F. (2017) Firm size distribution and employment fluctuations: theory and evidence. Research in Economics, 71(4), pp. 690-703. (doi: 10.1016/j.rie.2017.09.002)

Articles

Katikireddi, S. V. , Kopasker, D. , Pearce, A. , Leyland, A. H. , Rostila, M. and Richiardi, M. (2022) Protocol for a pan-European microsimulation model for health impacts of income and social security policies: health equity and its economic determinants (HEED). BMJ Open, (Accepted for Publication)

Kopasker, D. , Ejebu, O.-Z., Norwood, P. and Ludbrook, A. (2022) Longitudinal study of the effects of price and promotion incentives on purchases of unhealthy foods: evidence for restricting food promotions. BMJ Nutrition, Prevention and Health, (doi: 10.1136/bmjnph-2021-000323) (Early Online Publication)

Elliott, R., Kopasker, D. and Skåtun, D. (2021) Public-sector resource allocation since the financial crisis. International Journal of Manpower, 42(4), pp. 521-536. (doi: 10.1108/IJM-10-2019-0488)

Kopasker, D. , Islam, M. K., Gibson, J., Lau, Y.-S., Sutton, M., Askildsen, J. E., Bond, C. and Elliott, R. (2020) Skill mix and patient outcomes: a multi-country analysis of heart disease and breast cancer patients. Health Policy, 124(10), pp. 1074-1082. (doi: 10.1016/j.healthpol.2020.07.009) (PMID:32792201)

Allanson, P. F., Brown, E. A., Kopasker, D. and Kwiatkowski, A. (2020) An investigation of the stability of patients’ treatment preferences over the course of a clinical trial. Value in Health, 23(6), pp. 775-781. (doi: 10.1016/j.jval.2019.12.011) (PMID:32540236)

Kopasker, D. et al. (2019) Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment. British Journal of Dermatology, 180(4), pp. 902-909. (doi: 10.1111/bjd.16801) (PMID:29782648)

Kopasker, D. , Montagna, C. and Bender, K. A. (2018) Economic insecurity: a socioeconomic determinant of mental health. SSM - Population Health, 6, pp. 184-194. (doi: 10.1016/j.ssmph.2018.09.006) (PMID:30417065) (PMCID:PMC6215053)

Görg, H., Henze, P., Jienwatcharamongkhol, V., Kopasker, D. , Molana, H., Montagna, C. and Sjöholm, F. (2017) Firm size distribution and employment fluctuations: theory and evidence. Research in Economics, 71(4), pp. 690-703. (doi: 10.1016/j.rie.2017.09.002)

Book Sections

Kopasker, D. (2021) Good work and mental health in the post-Covid era. In: McCann, P. and Vorley, T. (eds.) Productivity and the Pandemic: Challenges and Insights from Covid-19. Edward Elgar Publishing Limited: Cheltenham, UK, pp. 119-131. ISBN 9781800374591 (doi: 10.4337/9781800374607.00015)

Research Reports or Papers

Kopasker, D. , Robertson, C., Aucott, L., Vadiveloo, T., Imamura, M., Manson, P., Walker, A., Urquhart, G., Brazelli, M. and Scotland, G. (2021) Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer [ID1605]. Other. Aberdeen HTA Group.

Robertson, C., Fielding, S., Walker, A., Kopasker, D. , Vadiveloo, T., Manson, P., Price, G., Brazzelli, M. and Scotland, G. (2020) Lorlatinib for Previously Treated ALK-positive Advanced Non-small-cell Lung Cancer [ID1338]. Other. Aberdeen HTA Group.